3528 results for «2012»

Filter By

3528 results

NSTEMI in patients in post CABG: a challenging combination

15 May 2024 – From EuroPCR 2024

This session focuses on the management of non-ST-elevation myocardial infarction (NSTEMI) in patients who have previously undergone coronary artery bypass grafting (CABG). Attendees will explore various case presentations and discussions on the challenges and treatment strategies for this complex clinical scenario, including the use of intravascular...

NSTEMI in patients in post CABG: a challenging combination

TAVI in bicuspid stenosis: complex situations

14 May 2024 – From EuroPCR 2024

This session comprises selected clinical case submissions focused on TAVI (Transcatheter Aortic Valve Implantation) in patients with bicuspid aortic stenosis. Participants will learn about complex scenarios, including fusion raphe, hostile bicuspid anatomy, large annulus, and early TAVR dysfunction. The session features case presentations followed by audience...

TAVI in bicuspid stenosis: complex situations

Stentless PCI

15 May 2024 – From EuroPCR 2024

This session explores various stentless percutaneous coronary intervention (PCI) strategies, including drug-coated balloon (DCB)-only PCI for chronic total occlusions and de-novo coronary lesions, as well as the use of magnesium resorbable scaffolds. Attendees will learn about the rationale, techniques, and outcomes of these "leave nothing behind"...

Stentless PCI

Management complications during PCI of calcified coronary lesions

14 May 2024 – From EuroPCR 2024

This session features selected clinical case submissions showcasing the management of complications that can arise during PCI (Percutaneous Coronary Intervention) of calcified coronary lesions. Participants will learn about various challenging scenarios, such as impacted diamond crown, stuck IVUS catheter post-stenting, and ruptured/fractured cutting balloon. The session...

Management complications during PCI of calcified coronary lesions

Treating the right valves: not always a straightforward task

15 May 2024 – From EuroPCR 2024

This session focuses on the challenges and complexities involved in the percutaneous treatment of right-sided heart valves, including the tricuspid and pulmonary valves. Attendees will learn from case presentations and discussions on various scenarios, such as recurrent right heart obstructive shock, paravalvular leak closure, and unusual...

Treating the right valves: not always a straightforward task

A percutaneous solution to transcatheter aortic valve thrombosis refractory to anticoagulation: valve-in-valve implantation of a supra-annular self-expanding transcatheter aortic valve

03 Aug 2020

A 56-year-old man with severe aortic stenosis underwent transapical TAVR in 2012. In 2017, the patient was referred for exertion dyspnea and transesophageal echocardiogram showed severe stenosis of the bioprosthesis...

Supra-annular valve-in-valve strategy for a transcatheter aortic valve thrombosis

The art of educating a fellow: A ‘mother-and-child’ relationship

22 May 2019

The history of EuroPCR - 30 years of innovation in education

04 Apr 2019

Discover the story and illustrations of the Course that has grown from a few dozen participants in 1989 to over 11,000!

ETC

Bentley acquired the GoBack catheter

13 Sep 2022

Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club

18 Jul 2019

Read this new document reflecting the expertise of European operators to promote CTO PCI in Europe and neighbouring communities

Authors :

A. R. Galassi, G. S. Werner, M. Boukhris, L. Azzalini, K. Mashayekhi, M. Carlino, A. Avran, N. V. Konstantinidis, L. Grancini, L. Bryniarski, R. Garbo , N. Bozinovic , A. H. Gershlick, S. Rathore, C. Di Mario, Y. Louvard, N. Reifart, G. Sianos, on behalf of the EuroCTO Club
EuroIntervention - Percutaneous recanalisation of chronic total occlusions: 2019 consensus document from the EuroCTO Club

Recruitment complete in FEVAR study for on-label use with Bentley BeGraft as bridging stent

21 Jul 2022

Recruitment complete in BEVAR study for on-label use of the Bentley BeGraft peripheral PLUS as a bridging stent

10 Mar 2023

FDA approves US oriented clinical study of Bentley’s BeGraft and Cook’s Zenith® Fenestrated+ Endovascular Graft for treatment of aortic aneurysms CAUTION: Investigational device. Limited by United States law to investigational use.

28 Jun 2023

Another milestone achieved – Bentley sold its 300,000th BeGraft

07 Jun 2023

A new percutaneous technique for effective vascular access site closure in patients undergoing TAVI and thoraco-abdominal aortic aneurysm repairs

09 Jan 2019

Results of the PASTE study

Authors :

Giovanni Sorropago, Gurbhej Singh, Antonio Sorropago, Andrea Sole, Jessica Rossi, Valerio Stefano Tolva, Eugenio Stabile, Filippo Scalise
EuroIntervention - A new technique for access-site closure

Overcoming the 360 degree radial artery loop

17 Mar 2021

A 77-year-old man was admitted for an elective diagnostic coronary angiogram. Following insertion of a 6Fr sheath into the distal right radial artery, a radial angiogram showed complete 360 degree radial artery loop...

Overcoming the 360 degree radial artery loop

A short history of the Euro4C Group

16 Jan 2019

Who better to recount its history than the inaugural President of the Euro4C Group? Additionally, insights are provided by the Chairman of PCR, the former EAPCI President, and a pivotal member of the editorial team.

Euro4C Group

Bentley buys key suppliers and engages employees in planned IPO

24 Apr 2023

UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial

19 Sep 2022

Ali Nazmi Calik provides his take on UNIVERSAL randomized clinical trial, which questioned whether routine ultrasonography guidance for CFA access for cardiac procedures reduces bleeding or vascular complications. This trial was presented by Sanjit S. Jolly during TCT 2022.

Author

Ali Nazmi Calik
UNIVERSAL: routine ultrasonography guidance for femoral vascular access for cardiac procedures - A randomized clinical Trial

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB: After revascularization of culprit lesions, assessment of coronary plaque size and composition matter!

17 Oct 2020

PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB trials were presented at TCT Connect 2020. Hector Garcia-Garcia provides a summary of the key messages.

Author

Hector Garcia
Live from TCT Connect 2020: PROSPECT II, COMBINE (OCT–FFR) and PROSPECT ABSORB
Didn’t find what you were looking for?